JP Morgan Put 290 AMGN 20.06.2025/ DE000JK6CQS7 /
2025-01-14 11:06:12 AM | Chg.- | Bid10:09:55 AM | Ask10:09:55 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.94EUR | - | 3.13 Bid Size: 10,000 |
3.21 Ask Size: 10,000 |
Amgen Inc | 290.00 USD | 2025-06-20 | Put |
GlobeNewswire
2024-08-29
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
2024-08-28
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
2024-08-15
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
2024-08-12
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2024-08-08
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
2024-08-08
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
2024-08-05
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
2024-08-01
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024